Table of Contents
<< Previous Issue | Jun 2009 (Vol: 2009, Issue: 6) | Next Issue >> |
- Section: Distribution & Marketing
-
Abbott’s Cholesterol Drug Deal with AstraZeneca
- Section: Editorial
-
Expanding into Emerging Markets
- Section: Licensing
-
ZymoGenetics Licenses Non-Core Assets to Seattle Life Sciences
-
Celgene and GlobeImmune form a Cancer Partnership
-
Antisoma Sells Oral Fludarabine to Sanofi-aventis
-
Another Oncology Deal for Sanofi
- Section: Mergers & Acquisitions
-
J&J Buys Cougar Biotech to Boost Oncology Presence
-
Watson Acquires Arrow in Bid for International Expansion
- Section: Research & Development
-
Agreement Between Roche and Tekmira to Advance RNAi Product Candidates
-
AstraZeneca and Merck in Anticancer Collaboration
-
GlaxoSmithKline to Access Concert’s Deuterium Technology